Dealing with a Lice Outbreak? Get the Best Treatment Now.

Sumadan Wash

Generic Name: sulfacetamide sodium and sulfur
Dosage Form: cream

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Sumadan
(Sodium Sulfacetamide 9% & Sulfur 4.5%)
WASH

Rx Only

In a Moisturizing
Novasome® Vehicle

Sumadan Wash Description

Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl) sulfonyl]-acetamide, monosodium salt, monohydrate. The structural formula is:

Each mL of Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash contains 90 mg of sodium sulfacetamide and 45 mg of sulfur in a formulation consisting of: butylated hydroxytoluene, C12-15 alkyl benzoate, caprylyl glycol, cetyl alcohol, cholesterol, chrysanthemum dendranthema, dimethicone, disodium oleamido MIPA sulfosuccinate, edetate disodium, ethylene brassilate, glyceryl stearate, hexylene glycol, lemon oil, magnesium aluminum silicate, magnesium chloride, magnesium nitrate, methylchloroisothiazolinone, methylisothiazolinone, niacinamide, nonoxynol-20, octoxynol-5, purified water, PEG-100 stearate, phenoxyethanol, propylene glycol, sodium cocoyl isotheionite, sodium methyl cocoyl taurate, sodium thiosulfate, stearyl alcohol, xanthan gum.

Slideshow: 18 Herbal Supplements with Risky Drug Interactions

Herbal and Dietary Supplements Deserve Your Attention

Sumadan Wash - Clinical Pharmacology

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash is indicated for the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

Contraindications

Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash are contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash is not to be used by patients with kidney disease.

Warnings

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.

FOR EXTERNAL USE ONLY. Keep away from eyes. Keep out of reach of children. Keep container tightly closed.

Precautions

General

If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.

Information for Patients

Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.

Carcinogenesis, Mutagenesis and Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential.

PREGNANCY

Category C

Animal reproduction studies have not been conducted with Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash. It is also not known whether Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash. However, small amounts of orally administered sulfonamides have been reported to be eliminated in human milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash is administered to a nursing woman.

PEDIATRIC USE

Safety and effectiveness in children under the age of 12 have not been established.

ADVERSE REACTIONS:

Although rare, sodium sulfacetamide may cause local irritation.

Sumadan Wash Dosage and Administration

Apply Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash once or twice daily to affected areas, or as directed by your physician. Wet skin and liberally apply to areas to be cleansed. Massage gently into skin for 10-20 seconds, working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing off Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash sooner or using less often.

How is Sumadan Wash Supplied

Sumadan® (sodium sulfacetamide 9% & sulfur 4.5%) Wash is available in a 16 fl. oz. (473 mL) bottle, NDC 43538-190-16.

Store at controlled room temperature 15°- 30° C (59°-86° F). Protect from freezing.

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Manufactured for:

MEDIMETRIKS
PHARMACEUTICALS, INC.

383 Route 46 West
Fairfield, NJ 07004-2402 USA

www.medimetriks.com

IP022-R2
Rev. 3/13

PRINCIPAL DISPLAY PANEL - 454 g Bottle Carton

NDC 43538-190-16

Rx Only
Sumadan

(Sodium Sulfacetamide 9% & Sulfur 4.5%)
WASH
In a moisturizing
Novasome® vehicle

Net Wt. 16 oz. (454 g)

MEDIMETRIKS
PHARMACEUTICALS, INC.

PRINCIPAL DISPLAY PANEL - 454 g Bottle Carton

NDC 43538-191-16

Rx Only
Sumadan

(Sodium Sulfacetamide 9% & Sulfur 4.5%)
KIT

CONTENTS:
1 - Sumadan™ (Sodium Sulfacetamide 9% & Sulfur 4.5%) Wash (Net Wt. 16 oz.)
1- Rehyla™ Wash Moisturizing Daily Wash (16 fl. oz.)

MEDIMETRIKS
PHARMACEUTICALS, INC.

Established Pharmacological Class
Substance Pharmacological Class
Rehyla Wash MOISTURIZING
Sumadan Wash 
sulfacetamide sodium and sulfur cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:43538-190
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
sulfacetamide sodium (sulfacetamide) sulfacetamide sodium 90 mg  in 1 g
sulfur (sulfur) sulfur 45 mg  in 1 g
Inactive Ingredients
Ingredient Name Strength
butylated hydroxytoluene  
Alkyl (C12-15) Benzoate  
caprylyl glycol  
cetyl alcohol  
cholesterol  
dimethicone  
edetate disodium  
glyceryl monostearate  
hexylene glycol  
lemon oil  
magnesium aluminum silicate  
magnesium chloride  
magnesium nitrate  
methylchloroisothiazolinone  
methylisothiazolinone  
niacinamide  
nonoxynol-20  
octoxynol-5  
water  
PEG-100 stearate  
phenoxyethanol  
propylene glycol  
sodium methyl cocoyl taurate  
sodium thiosulfate  
stearyl alcohol  
xanthan gum  
Product Characteristics
Color YELLOW Score     
Shape Size
Flavor Imprint Code
Contains         
Packaging
# Item Code Package Description
1 NDC:43538-190-16 1 BOTTLE, PUMP in 1 CARTON
1 454 g in 1 BOTTLE, PUMP
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 07/10/2011
SUMADAN 
sulfacetamide sodium and sulfur kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:43538-191
Packaging
# Item Code Package Description
1 NDC:43538-191-16 1 KIT in 1 CARTON
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 BOTTLE, PUMP 454 g
Part 2 1 BOTTLE, PUMP 454 g
Part 1 of 2
Sumadan Wash 
sulfacetamide sodium and sulfur cream
Product Information
     
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Sulfacetamide Sodium (Sulfacetamide) Sulfacetamide Sodium 90 mg  in 1 g
Sulfur (Sulfur) Sulfur 45 mg  in 1 g
Inactive Ingredients
Ingredient Name Strength
butylated hydroxytoluene  
Alkyl (C12-15) Benzoate  
caprylyl glycol  
cetyl alcohol  
cholesterol  
dimethicone  
disodium oleamido mipa-sulfosuccinate  
edetate disodium  
glyceryl monostearate  
hexylene glycol  
lemon oil  
magnesium aluminum silicate  
magnesium chloride  
magnesium nitrate  
methylchloroisothiazolinone  
methylisothiazolinone  
niacinamide  
nonoxynol-20  
octoxynol-5  
water  
PEG-100 stearate  
phenoxyethanol  
propylene glycol  
sodium methyl cocoyl taurate  
sodium thiosulfate  
stearyl alcohol  
xanthan gum  
Packaging
# Item Code Package Description
1 1 BOTTLE, PUMP in 1 CARTON
1 454 g in 1 BOTTLE, PUMP
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 06/01/2011
Part 2 of 2
REHYLA WASH 
inert cream
Product Information
     
Route of Administration TOPICAL DEA Schedule     
Ingredients
Ingredient Name Quantity
water  
glyceryl monostearate  
glycerin  
cetyl alcohol  
disodium oleamido mipa-sulfosuccinate  
cholesterol  
disodium laureth sulfosuccinate  
helianthus annuus seed wax  
caprylyl glycol  
propylene glycol  
phenoxyethanol  
sodium cocoyl isethionate  
cocamidopropyl betaine  
sodium methyl cocoyl taurate  
C13-14 isoparaffin  
sodium chloride  
niacinamide  
edetate disodium  
hexylene glycol  
laureth-7  
chamaemelum nobile flower  
hyaluronate sodium  
Packaging
# Item Code Package Description
1 1 BOTTLE, PUMP in 1 CARTON
1 454 g in 1 BOTTLE, PUMP
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Cosmetic 08/01/2011
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 08/01/2011
Labeler - Medimetriks Pharmaceuticals Inc. (019903816)
Establishment
Name Address ID/FEI Operations
IGI Laboratories 011036910 MANUFACTURE(43538-190, 43538-191)
Revised: 11/2013
 
Medimetriks Pharmaceuticals Inc.



Hide
(web4)